WallStreetZenWallStreetZen

NASDAQ: BNTC
Benitec Biopharma Inc Stock Ownership - Who owns Benitec Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Benitec Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Suvretta Capital Management LLCDirector2025-03-31670$13.22
$8.86kBuy
Suvretta Capital Management LLCDirector2025-03-315,057$13.22
$66.85kBuy
Suvretta Capital Management LLCDirector2025-03-311,267$12.63
$16.00kBuy
Suvretta Capital Management LLCDirector2025-03-319,503$12.63
$120.02kBuy
Suvretta Capital Management LLCDirector2025-03-26793,800$13.00
$10.32MBuy
Suvretta Capital Management LLCDirector2025-03-26106,200$13.00
$1.38MBuy
J. Kevin BuchiDirector2025-02-2751,813$3.86
$200.00kBuy
Suvretta Capital Management LLCDirector2024-12-242,288$11.25
$25.74kBuy
Suvretta Capital Management LLCDirector2024-12-2417,730$11.25
$199.46kBuy
Suvretta Capital Management LLCDirector2024-12-2324,360$10.98
$267.47kBuy

1 of 2

BNTC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BNTC insiders and whales buy or sell their stock.

BNTC Shareholders

What type of owners hold Benitec Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Suvretta Capital Management LLC38.21%8,960,009$123.20MInstitution
Franklin Resources Inc12.53%2,939,287$40.42MInstitution
Janus Henderson Group PLC11.16%2,616,427$35.98MInstitution
Adage Capital Partners GP LLC8.41%1,972,524$27.12MInstitution
Suvretta Capital Management LLC5.50%1,289,812$17.73MInsider
Nantahala Capital Management LLC3.57%838,095$11.52MInstitution
Steven Michael Oliveira2.85%668,123$9.19MInsider
Vanguard Group Inc1.28%300,021$4.13MInstitution
Schonfeld Strategic Advisors LLC1.11%260,417$3.58MInstitution
Infinitum Asset Management LLC0.90%210,000$2.89MInstitution

1 of 3

BNTC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BNTC81.01%8.93%Net BuyingNet Buying
IVA5.69%0.00%
TECX16.62%83.38%Net BuyingNet Buying
ERAS72.86%27.14%Net Buying
ALLO70.67%29.33%Net BuyingNet Selling
View Top Biotech Stocks

Benitec Biopharma Stock Ownership FAQ

Who owns Benitec Biopharma?

Benitec Biopharma (NASDAQ: BNTC) is owned by 81.01% institutional shareholders, 8.93% Benitec Biopharma insiders, and 10.06% retail investors. Suvretta Capital Management LLC is the largest individual Benitec Biopharma shareholder, owning 1.29M shares representing 5.50% of the company. Suvretta Capital Management LLC's Benitec Biopharma shares are currently valued at $17.73M.

If you're new to stock investing, here's how to buy Benitec Biopharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.